Stratified News from Protagen

What’s been happening in Dortmund in the last quarter? In our stratified newsletter, we try and keep you in the know with our very latest news, company developments, and off-topic musings…

Protagen lives to help tackle some of the most pressing issues in immuno-oncology and autoimmune diseases, and we could not do it without the relationships we have with our partners, collaborators, investors and friends! Our newsletter is designed to keep you up to date with all things Protagen, and charts our progress as we help establish precision diagnostic approaches for some of the world’s most devastating diseases.

If you would like to find out more about how we are working with our partners to help address market needs in immuno-oncology and autoimmune disease, contact us today.


January 2019 (LINK)


October 2018 (LINK)

July 2018 (PDF)

April 2018 (PDF)

January 2018 (PDF)


October 2017 (PDF)

July 2017 (PDF)

April 2017 (PDF)

January 2017 (PDF)


October 2016 (PDF)

July 2016 (PDF)

April 2016 (PDF)

January 2016 (PDF)


October 2015 (PDF)

July 2015 (PDF)

April 2015 (PDF)

January 2015 (PDF)


October 2014 (PDF)

July 2014 (PDF)




Protagen’s corporate leadership team combines over 40 years of commercial expertise and experience within the biotechnology industry, with a background spanning immunology, oncology, biomarker discovery and more.

Scientific Advisory Board

Protagen is currently setting up an international scientific advisory board with key opinion leaders from the immuno-oncology and autoimmune disease fields. These expert panels will support our efforts in engaging with the medical and scientific community to develop products that are aimed at market needs.


Protagen has a number of established and committed investors, but is always looking at entering into new partnerships to help progress its research and commercialization efforts. If you are interested in investing in the company, please contact us.


Protagen is always looking to expand its talented and experienced team. For information on some of the job roles available, simply click below.

Press Releases

View our press releases page to keep up to date with the latest news at Protagen.

Our Company

Protagen is dedicated to the development of powerful diagnostic tools that aid successful therapeutic development and facilitate improved treatment strategies in the areas of autoimmune disease and immuno-oncology.

Get in touch

Improving the treatment of cancer and autoimmune disease is our passion, and we always welcome the chance to discuss these topics with current and prospective customers, patients and clinicians alike.

We sometimes like to share the latest industry insights and company news, would you like to be added to our database?

11 + 7 =